You are here

  • Home
  • Archive
  • Volume 95, Issue 7
  • Response to ‘Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017’ by Checchi et al

Article Text

Article menu
Download PDFPDF
Miscellaneous
Letter
Response to ‘Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017’ by Checchi et al

https://doi.org/10.1136/sextrans-2019-054101

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Handling editor Anna Maria Geretti

    • Contributors Both authors participated in the analysis and interpretation of the data and the development of this letter. Both had full access to the data and gave final approval before submission.

    • Competing interests VB and SW are employees of the GSK group of companies. VB also holds shares in the GSK group of companies. GlaxoSmithKline Biologicals SA took in charge all costs associated with the development and publication of this short letter.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.